{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:40:02Z","timestamp":1791830402605,"version":"4.3.4"},"reference-count":25,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.5250","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T11:31:26Z","timestamp":1617967886000},"page":"e215250","source":"Crossref","is-referenced-by-count":37,"title":["Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women"],"prefix":"10.1001","volume":"4","author":[{"given":"De-Shen","family":"Wang","sequence":"first","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tao","family":"Hu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ren","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Zhen","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yan","family":"Luo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Pat","family":"Fong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Peking University Shenzhen Hospital, Shenzhen, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-wen","family":"Peng","sequence":"additional","affiliation":[{"name":"Chemotherapy Department, Zhongshan People\u2019s Hospital, Zhongshan, Guangdong Province, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-feng","family":"Zou","sequence":"additional","affiliation":[{"name":"Section 3 of Internal Medicine, Cancer Center of Guangzhou Medical University, Guangzhou, Guangdong, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Tan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hua","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, People\u2019s Republic of China"},{"name":"Research Unit of Precision Diagnosis and Treatment for Gastrointestinal Cancer, Chinese Academy of Medical Sciences, Guangzhou, People\u2019s Republic of China"},{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"issue":"10","key":"zoi210176r1","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Incidence of chemotherapy-induced nausea and emesis after modern antiemetics.","volume":"100","author":"Grunberg","year":"2004","journal-title":"Cancer"},{"issue":"6","key":"zoi210176r2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00520-010-0915-9","article-title":"Impact on daily functioning and indirect\/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a US population.","volume":"19","author":"Haiderali","year":"2011","journal-title":"Support Care Cancer"},{"issue":"27","key":"zoi210176r3","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","article-title":"Delayed nausea and vomiting continue to reduce patients\u2019 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.","volume":"24","author":"Bloechl-Daum","year":"2006","journal-title":"J Clin Oncol"},{"key":"zoi210176r4","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1007\/s00520-010-1003-x","article-title":"Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity\u2014state of the art.","volume":"19","author":"Grunberg","year":"2011","journal-title":"Support Care Cancer"},{"issue":"2","key":"zoi210176r5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.","volume":"22","author":"Tournigand","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"zoi210176r6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00520-005-0914-4","article-title":"Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.","volume":"14","author":"Hesketh","year":"2006","journal-title":"Support Care Cancer"},{"issue":"4","key":"zoi210176r7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1634\/theoncologist.2014-0229","article-title":"Aprepitant and fosaprepitant: a 10-year review of efficacy and safety.","volume":"20","author":"Aapro","year":"2015","journal-title":"Oncologist"},{"issue":"3","key":"zoi210176r8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.ejca.2003.08.028","article-title":"The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.","volume":"40","author":"de Wit","year":"2004","journal-title":"Eur J Cancer"},{"issue":"4","key":"zoi210176r9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two phase III randomized clinical trials.","volume":"104","author":"Gralla","year":"2005","journal-title":"Cancer"},{"key":"zoi210176r11","doi-asserted-by":"publisher","first-page":"v119","DOI":"10.1093\/annonc\/mdw270","article-title":"2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients.","volume":"27","author":"Roila","year":"2016","journal-title":"Ann Oncol"},{"issue":"4","key":"zoi210176r12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00520-009-0680-9","article-title":"Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study.","volume":"18","author":"Rapoport","year":"2010","journal-title":"Support Care Cancer"},{"issue":"3","key":"zoi210176r13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00520-016-3463-0","article-title":"Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types.","volume":"25","author":"Kim","year":"2017","journal-title":"Support Care Cancer"},{"issue":"5","key":"zoi210176r14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/BF00434947","article-title":"Quality of life consequences of chemotherapy-induced emesis.","volume":"1","author":"Lindley","year":"1992","journal-title":"Qual Life Res"},{"issue":"4","key":"zoi210176r15","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/bjc.2013.400","article-title":"A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy.","volume":"109","author":"Tanioka","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"zoi210176r16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00520-018-4464-y","article-title":"ASCO, NCCN, MASCC\/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients.","volume":"27","author":"Razvi","year":"2019","journal-title":"Support Care Cancer"},{"issue":"12","key":"zoi210176r17","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1200\/JCO.2005.09.050","article-title":"Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.","volume":"23","author":"Warr","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"zoi210176r18","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00520-010-0899-5","article-title":"Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin-cyclophosphamide-based chemotherapy.","volume":"19","author":"Warr","year":"2011","journal-title":"Support Care Cancer"},{"issue":"1","key":"zoi210176r19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40360-018-0278-2","article-title":"Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens.","volume":"20","author":"Yoshida","year":"2019","journal-title":"BMC Pharmacol Toxicol"},{"issue":"11","key":"zoi210176r20","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1200\/JCO.2003.11.126","article-title":"Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial.","volume":"21","author":"Rothenberg","year":"2003","journal-title":"J Clin Oncol"},{"issue":"9209","key":"zoi210176r21","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"zoi210176r22","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00520-011-1235-4","article-title":"Single-dose intravenous casopitant in combination with ondansetron and dexamethasone for the prevention of oxaliplatin-induced nausea and vomiting: a multicenter, randomized, double-blind, active-controlled, two arm, parallel group study.","volume":"20","author":"Hesketh","year":"2012","journal-title":"Support Care Cancer"},{"issue":"10","key":"zoi210176r23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.ejca.2015.03.024","article-title":"Combination antiemetic therapy with aprepitant\/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.","volume":"51","author":"Nishimura","year":"2015","journal-title":"Eur J Cancer"},{"issue":"1","key":"zoi210176r24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10147-016-1022-9","article-title":"Combination antiemetic therapy with aprepitant\/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea.","volume":"22","author":"Takemoto","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"zoi210176r25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jpainsymman.2013.06.012","article-title":"Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.","volume":"47","author":"Molassiotis","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"zoi210176r10","unstructured":"National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. Antiemesis, Version 2. 2020. Accessed October 20, 2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/antiemesis.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2778342\/wang_2021_oi_210176_1617280519.79323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T11:31:30Z","timestamp":1617967890000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2778342"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.5250","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]}}}